Rapid Results

Cytomegalovirus (CMV) IgM Antibody Rapid Test

Rapid detection of IgM antibodies to Cytomegalovirus (CMV) in human serum or plasma.

CE Certified
ISO 13485
Main image of Cytomegalovirus (CMV) IgM Antibody Rapid Test

Why Choose reOpenTest Infectious Disease Kits?

Our tests are engineered for accuracy, reliability, and ease of use, ensuring confidence in every result.

Fast Detection

Provides results in 10-15 minutes for quick assessment.

Ease of Use

Simple procedure suitable for various healthcare settings.

Early Detection

Identifies recent or current CMV infection.

Product Overview

The Cytomegalovirus (CMV) IgM Antibody Rapid Test is a qualitative immunoassay for the detection of IgM antibodies to CMV in human serum or plasma. It provides a quick and easy method for the preliminary diagnosis of acute CMV infection and results should be interpreted in conjunction with clinical findings and other laboratory data.

Technical Specifications

Detection Target CMV IgM antibodies
Sample Type Serum or Plasma
Methodology Immunochromatography
Detection Range Positive/Negative
Reaction Time 10-15 minutes
Storage Conditions 2-30u00b0C
Shelf Life 24 months

Procedure & Interpretation

Step-by-Step Procedure

  1. Collect serum or plasma sample.
  2. Apply sample to the test device.
  3. Wait 10-15 minutes.
  4. Read and interpret the results.

Result Interpretation

Positive Result
Positive: Visible line for IgM indicates a positive result for CMV IgM antibodies.
Negative Result
Negative: Only the control line is visible, indicating a negative result.
Invalid Result
Invalid: If the control line is not visible, the test is invalid and should be repeated.

Frequently Asked Questions

Detecting CMV IgM antibodies in pregnant women is important because it can indicate a recent or primary infection, which poses a higher risk of congenital CMV infection in the fetus.

In immunocompromised individuals, the interpretation can be more challenging due to potential atypical antibody responses. Results should be correlated with clinical presentation and other relevant diagnostic tests.

A positive result should be confirmed by more specific and quantitative methods, such as ELISA or PCR, to assess the viral load and determine the need for further management.

Technical Documents

Download product inserts and brochures for detailed information.

No technical documents are available at this time. Please check back soon.

Partner with reOpenTest

Provide your clients and patients with reliable diagnostic solutions.
Contact us today for bulk pricing and distribution opportunities.

Become a Distributor